BPTH - Bio Path Holdings - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BPTH is currently covered by 1 analysts with an average price target of $50.55. This is a potential upside of $48.78 (2755.93%) from yesterday's end of day stock price of $1.77.

Bio Path Holdings's activity chart (see below) currently has 5 price targets and 6 ratings on display. The stock rating distribution of BPTH is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for BPTH is $12, Lowest price target is $12, average price target is $50.55.

Most recent stock forecast was given by JONATHAN ASCHOFF from ROTH on 27-Mar-2024. First documented stock forecast 16-Jul-2019.

Best performing analysts who are covering BPTH - Bio Path Holdings:

Jonathan Aschoff Yi Chen

Currently out of the existing stock ratings of BPTH, 1 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

12

$10.19 (562.98%)

260

3 months 29 days ago

0/3 (0%)

$7.96 (197.03%)

Buy

240

$238.19 (13159.67%)

560

3 years 3 months 20 days ago

0/2 (0%)

$89.6 (59.57%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BPTH (Bio Path Holdings) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on BPTH (Bio Path Holdings) with a proven track record?

JONATHAN ASCHOFF

Which analyst has the current lower performing score on BPTH (Bio Path Holdings) with a proven track record?

YI CHEN

Which analyst has the most public recommendations on BPTH (Bio Path Holdings)?

Jonathan Aschoff has 4 price targets and 3 ratings on BPTH

Which analyst is the currently most bullish on BPTH (Bio Path Holdings)?

Yi Chen with highest potential upside - $238.19

Which analyst is the currently most reserved on BPTH (Bio Path Holdings)?

Jonathan Aschoff with lowest potential downside - $10.19

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?